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Nanoparticles (NPs) are in use to efﬁciently deliver drug molecules into diseased cells. The surfaces of
NPs are usually grafted with polyethylene glycol (PEG) polymers, during so-called PEGylation, to improve
water solubility, avoid aggregation, and prevent opsonization during blood circulation. The interplay
between grafting density sp and grafted PEG polymerization degree N makes cellular uptake of PEGy-
lated NPs distinct from that of bare NPs. To understand the role played by grafted PEG polymers, we
study the endocytosis of 8 nm sized PEGylated NPs with different sp and N through large scale dissi-
pative particle dynamics (DPD) simulations. The free energy change Fpolymer of grafted PEG polymers,
before and after endocytosis, is identiﬁed to have an effect which is comparable to, or even larger than,
the bending energy of the membrane during endocytosis. Based on self-consistent ﬁeld theory Fpolymer is
found to be dependent on both sp and N. By incorporating Fpolymer, the critical ligand-receptor binding
strength for PEGylated NPs to be internalized can be correctly predicted by a simple analytical equation.
Without considering Fpolymer, it turns out impossible to predict whether the PEGylated NPs will be
delivered into the diseased cells. These simulation results and theoretical analysis not only provide new
insights into the endocytosis process of PEGylated NPs, but also shed light on the underlying physical
mechanisms, which can be utilized for designing efﬁcient PEGylated NP-based therapeutic carriers with
improved cellular targeting and uptake.
© 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Nanoparticles (NPs) have demonstrated promising properties as
therapeutic carriers which can efﬁciently deliver drug molecules
into diseased cells to treat numerous physiological disorders [1,2].
In the NP-mediated drug delivery process, one of the most impor-
tant steps is the internalization of NPs, called ‘endocytosis’ [3e7].
Endocytosis is an energetically driven process by which the NPs are
enveloped by the lipid bilayer of the cell membrane. Cells import
and export selected extracellular molecules, as well as NPs, through
endocytosis and exocytosis, respectively. Depending on the cell
type, the internalization mechanism and the properties of the NPs,
the endocytosis process can involve a few different pathways:
phagocytosis, pinocytosis, and clathrin-dependent andl Engineering, Northwestern
0311, USA. Tel.: þ1 847 491
).
Ltd. This is an open access article uindependent receptor-mediated endocytosis [3,4,6]. Among them,
receptor-mediated endocytosis is the most efﬁcient pathway for
cellular uptake of NPs. In this process, the surfaces of NPs are coated
by ligands that recognize and bind to the cell-surface receptors. If
the particle is too small, the ligand-receptor binding strength is too
weak to overcome the energy barrier created by bending of the cell
membrane [8,9], and the NP cannot be fully internalized. On the
other hand, when the particle is too large, the cellular uptake of NPs
is prohibited as the receptors expressed over the cell membrane
have to diffuse to the site of NP invagination [8]. Therefore, endo-
cytosis may not occur at all or may possibly develop over a long
time period, limited by the diffusivity of receptors [8,10]. Experi-
mental studies reveal that the optimal NP diameter for receptor-
mediated endocytosis is about 25e50 nm [11,12], which agrees
well with theoretical predictions [8e10,13,14] and computer sim-
ulations [15e17]. Subsequently, the shape, surface charge, and
stiffness of NPs were found to play speciﬁc roles in endocytosis
[3e6,18e22].
In the design of the ﬁrst-generation (i.e. non-PEGylated) NPs,
particles with different sizes, shapes and surface charges werender the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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freely administrated drug molecules for potentially improving their
accumulation at the diseased sites; the importance of NP size and
surface charge has been well established through experiments
[11,12,23]. However, most of these experimental studies operated
with serum-free media or did not consider the serum-protein in-
teractions with NPs. In vivo data show that these ﬁrst-generation
NPs are rapidly cleared after injection [24]. Moreover, the NPs are
unstable and usually internalized by the immune cells (macro-
phages) during circulation. To overcome these problems, surfaces
of second-generation NPs were grafted with polymer such as
polyethylene glycol (PEG), which is known to be hydrophilic and
biocompatible. With the help of PEGylation, the second-generation
NPs demonstrated improved stability and targeting in biological
systems. At the same time, the properties of these NPs were
dramatically different. Due to the PEG-mediated shielding of the NP
surface charge PEGylated NPs can be well dispersed in solution.
More importantly, a ‘stealth’ shell is formed by the grafted PEG
polymer that tends to prevent clearance by the immune system
(opsonization) [25]. PEGylated NPs therefore display prolonged
blood circulation time. Furthermore, the cellular uptake of PEGy-
lated NPs can be reduced due to the steric interactions between
grafted chains and the cell membrane [19].
To improve the endocytosis of PEGylated NPs, all the free ends of
grafted PEG polymers are typically conjugated with targeting
moieties such as cell-penetrating peptides (CPPs) [26e28], argi-
nylglycylaspartic acid (RGD) peptides [29,30], or anti-HER2 anti-
bodies [19]. With the help of these speciﬁc ligand-receptor
interactions, the cellular uptake of PEGylated NPs is tremendously
enhanced. Like their ungrafted counterparts, PEGylated NPs display
size-dependent endocytosis, but the size dependence is more
complex. Oh et al. found that PEGylated gold (Au) NPs with
d ¼ 2:4 nm core diameters can be delivered into the nucleus, while
NPs with d ¼ 5:5 nm and d ¼ 8:2 nm can only be partially delivered
into the cytoplasm of a model COS-1 cell line [28]. For NPs with
d>16 nm, cellular uptake is prohibited and NPs are found at the
cellular periphery [28]. However, in other experiments, the PEGy-
lated Au NPs with d ¼ 15 50 nm were efﬁciently internalized by
cancer cells [19,30,31]. Therefore, there exists a critical question:
What are the design criteria for PEGylated NPs to be quickly accepted
by diseased cells?
In the design of PEGylated NPs, there are two basic design pa-
rameters for grafted PEG polymers: one is the number of mono-
mers per chain, N; the other is grafting density sp. These two
parameters govern the surface morphology of PEGylated NPs as
well their performance in the drug delivery process. However,
experimental studies reported a varying range of these two pa-
rameters. For example, the typical molecular weight of grafted PEG
polymer is about 550e5000 Da, corresponding to N ¼ 12e112
[26e30,32,33]. The reported grafting densities of PEG polymers are
within the range sp ¼ 0:2 2:0 chains/nm2 [26e30,32,33]. It is
therefore not surprising that different experiments report seem-
ingly contradictory ﬁndings for internalization behaviors of PEGy-
lated NPs, as they use different combinations of N and sp.
Although the above-mentioned experiments have uncovered
critical information about large scale interactions between PEGy-
lated NPs and cells, many atomic-level questions remain to be
answered, as they cannot be easily addressed by experiments. For
instance, the conformational and structural properties of PEGylated
NPs and their effects on drug delivery efﬁcacy are difﬁcult to be
resolved by experiments. To understand the role of grafted PEG
polymers during endocytosis, and in particular the effects of N and
sp, we have performed large scale dissipative particle dynamics
(DPD) simulations on internalization of PEGylated NPs. Existing
studies primarily focused on ﬁrst-generation NPs, eventuallyaugmented with targeting moieties [8e10,13,15e17]. Our simula-
tion results reveal that the endocytosis of PEGylated NPs heavily
depends on both N and sp. Especially, the free energy change of
grafted PEG polymer can play an important role during the endo-
cytosis process, which apparently remained unnoticed in previous
studies.
Section 2 describes the model and methods to simulate the
endocytosis process of PEGylated NPs as well as the self-consistent
ﬁeld (SCF) theory to quantify the free energy change of PEG poly-
mers. Section 3 contains the results from our DPD simulations and
SCF analysis, and illustrates how the endocytosis process can be
affected by the N and sp. Section 4 discusses the ﬁndings of the
current work and compares them with experimental observations.
Conclusions are drawn in Section 5.
2. Model and methodology
2.1. DPD simulation details
The coarse-grained molecular dynamics simulations adopted in
this work are based on the DPD technique, a Lagrangian method
developed for mesoscale simulations with hydrodynamic in-
teractions. DPD has been successfully and widely used to study the
behavior of biomembranes [20,22,34e36]. Tomodel a large piece of
lipid bilayer efﬁciently, we adopt the lipid model developed by
Groot and Rabone [34]. In this model, the lipid molecule is repre-
sented by the H3(T5)2 model (Supporting Information (SI) Sections
1.1, 1.2 and Fig. S1), where H and T denote the hydrophilic lipid
heads and hydrophobic lipid tails, respectively. In the snapshots,
the hydrophilic heads and hydrophobic tails are represented by the
ice-blue beads and silver lines, respectively. The bending modulus
and viscosity of the self-assembled lipid bilayer are found to agree
reasonably well with experimental measurements [34]. Moreover,
such a model has been successfully applied to study the trans-
location and endocytosis of different NPs [16,20e22,35,37]. In
modeling the lipid bilayer, we assume that there are ~50% lipids
coated with receptors to accelerate the DPD simulations, which has
been proven to be a useful estimate in previous works [15,20,21].
The heads of these lipids attract the targeting moieties conjugated
at the free ends of grafted chains, as described in SI Sections 1.3 and
1.4. These lipids are randomly distributedwithin themembrane. All
the DPD simulations are performed in the NVT ensemble with time
step Dt ¼ 0:01 (dimensionless Lennard-Jones unit).
To maintain the zero lateral tension of the lipid bilayer during
the DPD simulation, we adopted the N-varied DPD method to
mimic a real cell membranewith large area-to-volume ratio [38]. In
the N-varied DPD method, the lateral tension is maintained by
monitoring the lipid number per area (LNPA) of the membrane,
instead of the lateral force/pressure. The boundary region of the
lipid membrane behaves like a reservoir of lipids in the DPD sim-
ulations. The LNPA of the boundary region is kept constant by
adding/deleting lipid molecules. Simultaneously, the correspond-
ing number of solvent beads is deleted/added to maintain the
particle density of the whole system. Note that LNPA is directly
related to the area per lipid. Thus, the N-varied DPD method offers
an easy way to control lateral tension of membrane and supplies
excess membrane area to release the tension induced by the
internalization of PEGylated NPs. The N-varied DPD method has
been successfully adopted to study the budding behaviors of
multicomponent membranes [38], internalization of ligand-coated
rigid NPs [39,40], as well dendrimer-like soft NPs [37]. More details
are given in SI Section 1.5.
The core of our PEGylated NP is formed by 1566 close-packed
‘beads’ arranged on a FCC lattice circumscribed by a sphere of
diameter d ¼ 8 nm. The lattice constant is ax0:90 nm. The close
Y. Li et al. / Biomaterials 35 (2014) 8467e8478 8469packing prevents water and other beads to enter the interior of the
core. During the DPD simulation, all the beads comprising the core
move as a rigid body. PEG polymers are permanently grafted at
randomly selected surface beads in accord with the given sp. For
simplicity, a coarse-grained model established for PEG polymers
[41] has been adopted in our DPD simulation. Within this model,
each PEG monomer has been coarse-grained into a single bead. All
these beads are consecutively connected by harmonic springs. The
bending energy of a trimer, formed by three successive connected
beads, is also considered in order to maintain the backbone stiff-
ness of PEG [41]. Such a polymer model in our DPD simulations can
correctly reproduce the radius of gyration and end-to-end distance
of PEG polymers with different molecular weights obtained from
all-atomistic and coarse-grained simulations, as reported by Lee
et al. [41] (Fig. S2 in SI). The interaction parameters between PEG
and lipid molecules are calibrated against experimental results
(Table. S1 in SI), as discussed by Groot and Rabone [34]. Note that
the PEG polymer is hydrophilic and its repulsive interaction with
lipid tail (hydrophobic) is much larger than that with lipid head
(hydrophilic).
We investigate a homologous series of grafting densities spz
0.2, 0.4, 0.6, 0.8, 1.0, 1.2, 1.4 and 1.6 chains/nm2, corresponding to an
integer-valued number M ¼ pd2sp ¼ 40, 80, 121, 161, 201, 241, 281
and 322 tethered chains, as shown in Fig. 1. Note that the different
grafting densities sp considered in this work arewithin the range of
experimentally studied grafting densities of PEG polymers, i.e.
0 (ungrafted) to 2.0 PEG/nm2 [28,31,33]. It is known that PEGylation
can reduce the interaction strength between NPs and the cell
membrane due to a hydrophilic stealth shell formed around the NP
surface. Thus, the cellular uptake of PEGylated NPs is prohibited
because of the inability of the NP-membrane interaction to over-
come the steric hindrance of PEG polymers. To include this mech-
anism, targeting moieties (ligands) are covalently bonded to the
free ends of all grafted chains, allowing them to speciﬁcally
recognize the expressed receptors over the cell membrane in the
previous experiments [28e30,32]. The cellular uptake of PEGylated
NPs is then greatly enhanced through speciﬁc ligand-receptor0.2 chains/nm2 0.4 chains/nm2
1.2 chains/nm21.0 chains/nm2
Fig. 1. Model setup for PEGylated NPs with different grafting densities sp. The diameter of
weight of 838 Da. With sp increasing from 0.2 to 1.6 chains/nm2, the conformation of graf
detailed discussions in SI Section 2). The core of PEGylated NP is colored yellow. The PEG
colored cyan and blue, respectively. These targeting moieties have attractive interactions w
molecules are not rendered here. (For interpretation of the references to colour in this ﬁgubinding. To mimic this effect in our modeling, we consider that
all free ends of grafted chains have attractive interactions with
receptors coated on the heads of lipids (see Fig.1 and SI Section 1.4).
These attractive interactions have beenwell deﬁned in the previous
computational studies to mimic the speciﬁc ligand-receptor in-
teractions [15,20,42,43].
2.2. Self-consistent ﬁeld theory
We employ the SCF theoretical approach [44,45] to estimate the
volume fraction proﬁles for each of the N monomers along a
representative tethered chain separately. The SCF result allows us to
calculate the radial volume fraction proﬁle fðrÞ of the spherical
brush, the volume fraction proﬁle of the terminal monomers, fðrÞ,
and the corresponding free energy, Fp. We ﬁnd that the measured
PEG proﬁles are recovered using a simplest classical model of a
polymer under good solvent conditions, that is characterized by a
dimensionless mixing free energy density vfmðfÞ ¼ tf2 þwf3 with
t ¼ w ¼ 1, where v ¼ 0:0633 nm3 denotes the excluded volume of a
PEG monomer. Within the SCF we basically aim at minimizing a
single chain free energy functional that is composed of an elastic
and interaction part,
Fp
kBT
¼ 3
2
〈r2ee〉
R20
þ
Z
fmðfÞd3r [1]
where 〈r2ee〉 ¼ V1
R ðr  d=2Þ2fd3r is the mean squared extension
of a polymer that is tethered on a sphere of diameter d, properly
normalized by the occupied chain volume V ¼ R fd3r ¼ Nv, and
R0 ¼ R0ðNÞ stands for the equilibrium size of a PEG polymer, that is
intermediate between its gyration radius and mean squared end-
to-end distance. We employ R20 ¼ 〈R2ee〉=e using the available
〈R2ee〉ðNÞ values for a single PEG chain in water (Fig. S2 in SI). The
above free energy is minimized with respect to the volume fraction
proﬁle, subject to the constraints of conserved V and the tethering
condition, fðr< d=2Þ ¼ 0. A most common numerical imple-
mentation of the related optimization problem on a geometry-0.6 chains/nm2 0.8 chains/nm2
1.6 chains/nm21.4 chains/nm2
the core is dz8 nm and the PEG has N ¼ 18 monomers, corresponding to a molecular
ted PEG polymers is transformed from the ‘mushroom’ to the ‘brush’ regime (see the
polymers and targeting moieties conjugated with free ends of the grafted chains are
ith receptors attached to the heads of lipid molecules. For clarity, the solvent (water)
re legend, the reader is referred to the web version of this article.)
Table 1
Effect of grafting density sp (or number of tethered chains, M) on the radius R of
PEGylated NPs, the average volume Vpolymer occupied by a single grafted chain,
radius of gyration Rg, and end-to-end distance Ree of grafted chains. The core
diameter is 8 nm and the grafted PEG length is N ¼ 18 (corresponding to molecular
weight 838 Da). ‘Before’ and ‘After’ indicate the values for Ree of grafted chains
before and after endocytosis, which are calculated at ligand-receptor binding
strength εb ¼ 6:2kBT . Fpolymer represents the free energy change of grafted chains
before and after endocytosis. The radius R is deﬁned as the mean distance between
targeting moieties and center of the PEGylated NP. Vpolymer is obtained by dividing
the volume difference of NPs before and after PEGylation by the number of grafted
chains M.
Before endocytosis After endocytosis
sp
Chains/nm2
M Ra
nm
Vpolymer
a
nm3
Rg
nm
Ree (before)
nm
Ree (after)
nm
Fpolymer
b
kBT
0.2 40 5.69 12.56 0.99 2.66 N/A N/A
0.4 80 5.82 6.96 0.99 2.67 2.93 10.00
0.6 121 5.98 5.20 1.01 2.74 2.77 41.86
0.8 161 6.16 4.41 1.02 2.82 2.89 78.07
1.0 201 6.31 3.90 1.04 2.89 2.96 83.29
1.2 241 6.46 3.57 1.05 2.96 2.90 156.18
1.4 281 6.60 3.34 1.07 3.04 2.90 120.47
1.6 322 6.76 3.19 1.08 3.13 3.04 120.83
a The R and Vpolymer of these NPs are found to be in good agreement with
experimental results [46], as discussed in SI Section 2.
b Fpolymer is calculated based on the self-consistent ﬁeld theory, according to
Eq. (1).
Y. Li et al. / Biomaterials 35 (2014) 8467e84788470adapted grid had been introduced by Scheutjens and Fleer [46]. We
follow the implementation described in detail by Wijmans and
Zhulina [45]. To this end, a single ﬂexible polymer is grown
sequentially, using a constant bond length a ¼ 0:33 nm (for PEG),
starting from a spherical surface of diameter d. During (a priori)
random growth within the space surrounding the nanoparticle, the
representative chain creates its own radial volume fraction proﬁle
(with multiplicity of the number of tethered chains, recorded
within spherical shells of thickness a) to which it reacts, as the
volume fraction enters the probability to choose from all possible
directions, at each step of the growth procedure. To be precise, it
reacts by its current radial coordinate r to the dimensionless ex-
change chemical potential UðfÞ=kBT ¼ vf 0mðfÞ ¼ 2fþ 3f2 con-
tained in a segment weighting factor G1ðrÞ ¼ expðUðrÞ=kBTÞ,
wherewe recall that f ¼ fðrÞ. The problem is thus closely related to
a diffusion process in the presence of a potential and boundary, and
can in principle also be formally treated using Green's functions.
Accordingly, one introduces GnðrÞ, the average statistical weight of
an n-mer of which the last segment is located in layer r:
GnðrÞ ¼ Gn1ðrÞG1ðrÞ for n ¼ 2;…;N, where the spatial average is
taken over a sphere of radius a, centered at r. We are left with a
closed set of coupled equations, where the averages play the role of
the coefﬁcients of a linear system of equations that can be solved in
an iterative fashion using simplematrix inversions. Due to head-tail
symmetry of the polymer chains, the volume fraction proﬁle of an
n-mer is subsequently obtained from the solution GnðrÞ via
fnðrÞ ¼ CnGnðrÞGNnþ1ðrÞ=G1ðrÞ, where the Cn’s are normalization
factors that follow from v ¼ R fnðrÞd3r and ﬁnally fðrÞ ¼PNn¼1fnðrÞ
as well as fNðrÞ are obtained. Because the volume fraction proﬁles
fnðrÞ of the unwrapped PEGylated NP are all well recovered (as
given in the following section), we can estimate the free energy
difference Fpolymer ¼ DFp between wrapped and unwrapped
PEGylated NP upon inserting the two measured fðrÞ’s separately
into Eq. (1).
3. Results
3.1. Morphology of PEGylated NPs
Before simulating the internalization pathway of PEGylated NPs,
our NPs have been fully equilibrated in the water environment
(conﬁgurations shown in Fig. 1). When sp is very small, the
conformation of chains is in ‘the mushroom’ regime. However,
when sp is high, their conformation is in the ‘brush’ regime (see SI
Section 2 for a detailed discussion, and Eq. (2)). These observations
are consistent with the theoretical results presented by Szleifer and
Carignano [47]. These different conformations are directly related
to the protein absorption capabilities of PEGylated NPs, which have
been studied both theoretically and experimentally [33,48]. The
endocytosis of PEGylated NPs can be greatly inﬂuenced by these
different conformations as well. The particle density distribution
functions of targeting moieties to the center of PEGylated NP are
given in Fig. S5 of SI. When sp is very small, the targeting moieties
are mostly distributed within the hydrophilic stealth shell and
cannot effectively interact with the receptors. With increasing sp,
more targeting moieties can be found outside of the stealth shell.
Therefore, the PEGylated NPs with high grafting (ligand) densities
can be more easily taken up by the cell due to strong ligand-
receptor interactions.
The radius R of PEGylated NPs linearly increases with increasing
sp, as can be seen in Table 1 and Fig. S6 of SI. The average volume
occupied by a single grafted chain Vpolymer is obtained by dividing
the volume difference of the NP before and after PEGylation by the
number of PEG chains per NP, Vpolymer ¼ ðp=6Þð8R3  d3Þ=M. As
shown in Table 1, Vpolymer decreases nonlinearly with the incrementof sp, in contrast with the size of PEGylated NPs. The experimen-
tally observed size of PEGylated Au NPs and Vpolymer of grafted PEG
chains [33] are found to be in good agreement with our DPD sim-
ulations (SI Section 2). These agreements further verify and validate
our model for PEGylated NPs. Moreover, smaller values of Vpolymer
indicate a larger loss in conformational degrees of freedom by
grafted PEG chains, which has also been observed in experiments
[33]. This loss in conformational degrees of freedom can prevent
water molecules from being absorbed by the grafted chain and can
increase the thermodynamic barrier to serum protein adsorption
[33,49], consistent with our observations of the conformational
changes of grafted PEG polymers (Fig. 1).
The results on grafted chains' radii of gyration Rg and end-to-
end distances Ree further conﬁrm our above observations
(Table 1). At high grafting densities, the PEG chains are more
stretched and ﬂattened for larger Rg and Ree values due to their
steric (repulsive) interactions. Note that R2ee ¼ 6R2g for equilibrium
chains with random coil conformations. However, R2ee >6R
2
g in the
grafted state, as shown in Table 1, which also indicates that the
conformation of chains has been dramatically changed. Changes in
the conformational degrees of freedom of grafted PEG polymers are
directly related to their free energies.
Within the SCF theory that we use to calculate detailed infor-
mation about the underlying volume fraction fðrÞ of PEG chains
within the corona of the NPs, the free energy of a single chain
consists of an elastic and interaction part, cf. Eq (1), that can be
rewritten as,
Fp
kBT
¼ 3
2
〈r2ee〉
R20
þ N〈vfmðfÞ
f
〉 ¼ 3
2
〈r2ee〉
R20
þ tN〈f〉þ… [2]
since averages are calculated with the yet unknown volume
fraction proﬁle fðrÞ via 〈A〉 ¼ R Afd3r= R fd3r. The free energy
expression Eq. (2) reduces to the more familiar Flory free energy
within the strong stretching assumption, where 〈ree〉 ¼ R2ee, and
where f ¼ fðrÞ is considered to be the spatially homogeneous ratio
between occupied, Nv, and accessible volume per single chain. The
accessible volume VdðReeÞ of a PEG chain tethered to a spherical NP
of diameter d is the Mth fraction of the corona volume,
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f ¼ Nv=VdðReeÞ into Eq. (2) yields
Fp
kBT
¼3
2
R2ee
R20
þtN Nv
VdðReeÞ
x
3
2
R2ee
R20
þ
8>><
>>:
tN
Nv
R3ee
þ…

R2ee<1
.
sp :mushroom

tN
Nv
Ree

sp
þ…

R2ee>1
.
sp :planar brush

[3]
where we explicitly mentioned in Eq. (2) the limiting mushroom
(single free chain, M ¼ 1, R2ee <1=sp) and planar brush ðR2ee >1=spÞ
special cases of themore general Flory-type expression. Under ideal
good solvent conditions, t>0 and higher order virial coefﬁcients
are of minor relevance. In that extremal case Fp is readily mini-
mized with respect to Ree to obtain the equilibrium Ree for the
unconﬁned, unwrapped PEGylated NP as function of N and sp [50].
While the Flory approach yields an analytic result that can be used
as a ﬁrst approximation for a hydrophilic polymer like PEG inwater,
its assumptions are not met for the realistic scenario under study;
in particular the chains are not fully stretched, fðrÞ is not a constant,
and the third virial coefﬁcientw cannot be neglected. Moreover the
situation is more complex as we are faced with a curved tethering
surface. These aspects are fully taken into account within the un-
approximated SCF that we apply to a PEGylated NP (Section 2.2).t=0
t=12ns
t=49n
t=243ns t=486ns t=730
Fig. 2. Representative DPD simulation snapshots for endocytosis of PEGylated NP with core
bending stage (0< t <122 ns), membrane monolayer protruding stage (122< t <750 ns) an
chains/nm2. The ligand-receptor binding strength is εb ¼ 6:2kBT . The color scheme is the sam
blue beads and silver lines, respectively. The lipid heads coated with receptors are represenThe simple Eq. (2) serves to highlight that the free energy of grafted
PEG chains is highly dependent on the end-to-end distance Ree.
This aspect will be further discussed in the following part.3.2. Internalization pathway of PEGylated NPs
Fig. 2 shows the representative receptor-mediated endocytosis
pathway of PEGylated NPs. Depending on the position of the
PEGylated NP, the wrapping process can be divided into three
stages: membrane bending stage (0 < t < 122 ns), membrane
monolayer protruding stage (122 ns < t < 750 ns) and equilibrium
stage (t > 750 ns). During the membrane bending stage, the tar-
geting moieties conjugated at free ends of the grafted PEG chains
recognize and bind to the receptors (lipid heads) sitting in the
membrane. Simultaneously, the membrane starts to bend and to
wrap around the PEGylated NP. With time increasing, more and
more receptor molecules diffuse into the membrane bending re-
gion and form bindings with targeting moieties on PEGylated NP. In
this stage, the energy released by the ligand-receptor binding
provides the major driving force for the membrane to bend and
wrap around the PEGylated NP, until the wrapping process enters
the second stage. At the time tz 122 ns, the majority of the
PEGylated NP is wrapped by the membrane and the upper leaﬂet of
the membrane starts to protrude and wrap the PEGylated NP from
the top. The lower leaﬂet of the membrane, however, bends slowly
and weakly, compared with its performance during the ﬁrst stages
t=122ns
ns t=973ns
diameter dz8 nm. The whole process can be classiﬁed into three stages: membrane
d equilibrium stage (t >750 ns). The grafting density of PEG with N ¼ 18 is sp ¼ 1:6
e as Fig. 1. The hydrophilic heads and hydrophobic tails of lipids are represented by ice-
ted by gray beads. For clarity, the solvent (water) molecules are not rendered.
Y. Li et al. / Biomaterials 35 (2014) 8467e84788472(membrane bending stage). Later on, the PEGylated NP is slightly
pulled upwards and located around the center of membrane to
reduce the bending energy penalty of the lower membrane
monolayer. At tz 750 ns, the PEGylated NP is fully and symmet-
rically wrapped between the upper and lower leaﬂets of the
membrane. A similar wrapping pathway has been found for hy-
drophilic NPs decorated by ligands only (without PEGylation)
[21,40,51].
Here we should emphasize that the protrusion of the upper
leaﬂet of the membrane is induced by the strong ligand-receptor
binding and the high ﬂuidity of the lipid bilayer, as discussed by
Yue et al. [40]. The monolayer protrusion regulated wrapping can
be further transformed to the complete internalization, through a
small amount of external force (e.g 6.4 pN) [40], induced by actin
ﬁlaments in the cell [52] or actin polymerization [3,53].
The internalization rate is strongly dependent on the grafting
(ligand) density sp of PEG polymers. The wrapping ratio, deﬁned
as the wrapped area fraction of the PEGylated NP, is plotted
versus endocytic time in Fig. 3. At ligand-receptor binding
strength ε ¼ 6:2kBT , most of the PEGylated NPs can be internal-
ized within 4000 ns, except the PEGylated NP with low
sp ¼ 0:2 chains/nm2. Similar to the internalization pathway
shown in Fig. 2, these PEGylated NPs are symmetrically enveloped
by the membrane at the last stage of the process. Moreover, the
wrapping speed slows signiﬁcantly with decreasing sp. When
sp  0:2 chains/nm2, the PEGylated NP can only be partially
wrapped by the membrane, even after 5000 ns, as given in the
snapshots of Fig. 3 and Fig. S7 in SI.
3.3. Free energy change during endocytosis
When the PEGylated NP interacts with the cell membrane, there
are three major contributions to the free energy of the system, F .
The ﬁrst is the bending energy Fmemb of the membrane, which is
related to the curvature change of the membrane during endocy-
tosis. The second is the speciﬁc ligand-receptor interaction Fligand.
The third is the non-speciﬁc free energy Fpolymer of the grafted PEG
chains due to the steric (repulsive) interactions between grafted
chains and the membrane. Thus, F ¼ Fmemb þ Fligand þ Fpolymer.
Note that the free energy changes induced by the thermal ﬂuctu-
ations of the membrane and entropy loss of translation associatedFig. 3. Effect of grafting density on the wrapping ratio of PEGylated NPs. The core diamet
strength is εb ¼ 6:2kBT . Wrapping ratios 0 and 1 denote the unwrapped and completely w
grafting densities, marked by A1-A4, are given on the right. The color scheme is the samewith receptors are much smaller than these three major contribu-
tions [54,55]. Therefore, these terms are ignored in calculating the
free energy change of the whole system F . During endocytosis, as
shown in Fig. 2, the membrane curvature change will enlarge
Fmemb. At the same time Fligand will be reduced due to the ligand-
receptor binding. However, a more subtle question is To what
extent does the free energy Fpolymer of the grafted PEG polymers
change? As we learned from Vpolymer in Table 1, when the PEG
chains are grafted to the core of a NP, they lose conformational
degrees of freedom. Their corresponding entropy DS reduces, while
increasing the free energy of PEG chains as Fpolymer ¼ TDS (T is the
temperature). Similarly, when the PEGylated NP is wrapped by the
membrane, the conformational degrees of freedom of the PEG
chains are further reduced as they are now conﬁned between the
core of the NP and the membrane. Hence Fpolymer can be greatly
enlarged, when the PEGylated NP is enclosed within the mem-
brane. Therefore, during endocytosis of the PEGylated NPs, both
Fmemb and Fpolymer are increased, while Fligand is decreased,
providing the driving force for PEGylated NP to be internalized. The
reduction of Fligand should be larger than the increment of Fmemb
and Fpolymer. Otherwise, the endocytosis cannot occur spontane-
ously. Note that here we study the ligand-receptor mediated
endocytosis of NPs. The thermodynamic driving force is the ligand-
receptor binding, which does not necessarily require either the
expenditure of ATP or the presence of lipid rafts [8,9,15]. Since the
free energy changes of membrane bending Fmemb and ligand-
receptor binding Fligand during endocytosis have been extensively
studied in the previous works [8e10,18,56,57], we will brieﬂy
discuss them in the following part, and mainly focus on the free
energy change of grafted PEG polymer Fpolymer.
The free energy change Fmemb induced by the curvature change
of the membrane can be analytically quantiﬁed, which has been
discussed in the previous works [8e10,18,37,56e58]. Compared
with its ﬂat counterpart, the free energy of the membrane wrap-
ped around a NP surface is Fmemb ¼ 8pk [56,57], obtained by
integrating the curvature over the spherical NP and ignoring the
contributions from surface roughness of the monolayer. Here
kz10kBT is the bending rigidity of the model membrane [36,37].
Therefore, Fmembz251kBT , regardless of the size of wrapped
PEGylated NP. Here we should emphasize that the model mem-
brane is only formed by phospholipids, which mimics the behaviorA1 A2
A3 A4
er of PEGylated NPs is 8 nm with grafted PEG of N ¼ 18. The ligand-receptor binding
rapped state, respectively. Snapshots for endocytosis of PEGylated NPs with different
as Fig. 2.
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(POPC) bilayer [22,35]. However, in the experiments, the cell
membranes are more complicated, as they contain cholesterol and
possibly skeletal proteins, and would be expected to be more rigid
(larger value of k) [59].
The free energy change Fligand induced by ligand-receptor
binding can also be analytically calculated. The binding strength
εb is related to the ligand-receptor interaction potential
Uligandreceptorij deﬁned in our DPD simulations. The relationship
between binding strength εb and energy well depth εligandreceptor
in Uligandreceptorij is given in SI Section 1.4 and Fig. S3. Accordingly,
Fligand ¼ Mεb when the PEGylated NP is internalized by the cell,
where M denotes the number of targeting moieties per NP, as we
consider that all the free ends of grafted PEG chains are conjugated
with targeting moieties, which mimics the experimental condition
[29,30,32,33].
As is evident from Eq. (2), the free energy change Fpolymer of
grafted chains is captured by their end-to-end distance Ree during
the endocytosis. To understand this effect, we monitor the change
of chain's end-to-end distance Ree during endocytosis process (SI
Section 3 and Fig. S8). For different grafting densities, we ﬁnd
that the Ree can be slightly enlarged during the initial stage, as the
free ends of grafted PEG chains are stretched out to bind with the
receptors on the cell membrane. However, after the PEGylated NPs
have been fully wrapped by the membrane, the Ree suddenly drops
to a smaller value, due to the conﬁnement induced by the cell
membrane. All these changes of Ree indicate a free energy change
Fpolymer of grafted PEG polymers, before and after endocytosis,
which needs to be understood in detail.
To quantify the free energy change of grafted PEG polymers, we
adopt the SCF theory developed for polymer brushes (Eq. (1)). From
the SCF calculation, the volume fraction proﬁles of both grafted PEG
polymers and their free ends can be directly predicted before the
PEGylated NP is wrapped by the membrane. As shown in Fig. 4, the
volume fraction proﬁles fðrÞ of grafted PEG polymers and their free
ends can also be directly calculated from our DPD simulations. In
Fig. 4a, the fðrÞ proﬁles predicted by the SCF calculations are given
as solid lines. Interestingly, the volume fractions given by our DPD
simulations are in good agreement with the SCF calculation results,
except for fðrÞ close to the surface of the core (rx4 nm). As we
learn from the snapshots of PEGylated NPs (Fig. 1), the core of the
PEGylated NP is not a perfect sphere, as it was formed by beads
arranged on a FCC lattice. However, in our SCF calculations, wea
Fig. 4. Volume fraction proﬁles fðrÞ of grafted PEG polymers and their free ends (conjuga
endocytosis. The core diameter of PEGylated NP is about 8 nm, grafted with N ¼ 18 at sp ¼assume that the core of the NP is a perfect sphere. Due to this tiny
difference, the fðrÞ proﬁles given by DPD simulations slightly
deviate from the SCF predictions, when rx4 nm (around the sur-
face of the core). We should emphasize that the fðrÞ proﬁles for the
unwrapped PEGylated NPs with grafting densities
sp ¼ 0:4 1:6 chains/nm2 are all well recovered by the SCF calcu-
lations (SI Fig. S9) without changing any parameter except for sp. In
light of these agreements, the free energy difference Fpolymer of
grafted PEG polymers, before and after endocytosis, can now be
directly estimated upon inserting the two measured fðrÞ proﬁles,
from wrapped and unwrapped PEGylated NP, into Eq. (1).
According to the SCF calculation (Eq. (1)) and the volume frac-
tion proﬁles fðrÞ given by the DPD simulations, the free energy per
monomer of grafted chains Fp=NkBT is plotted in Fig. 5a. Fp=NkBT is
monotonically increasing with the number of grafted chains
(grafting density) increasing, not matter before or after endocy-
tosis, in agreement with the changes of Vpolymer (Table 1). More-
over, the value of Fp=NkBT has been enlarged, when the PEGylated
NP has been taken up the cell, as we expected from above discus-
sions. Taking the free energy difference of Fp=NkBT shown in Fig. 5a,
the free energy change Fpolymer of PEG polymers during endocytosis
is immediately available and shown in Fig. 5b (also listed in Table 1).
Due to the different numbers of grafted PEG chains, Fpolymer varies
from 10 to 156 kBT for N ¼ 18. As we mentioned in the above dis-
cussion, the free energy change induced by membrane bending is
about Fmembx251kBT (dashed line in Fig. 5b). Thus, the free energy
change Fpolymer of grafted PEG polymer during the internalization
process is found to be comparable with Fmemb when the grafting
density is large. We should emphasize that in the previous studies,
the primary focus in the study of the endocytosis process was
placed on the free energy change of the membrane Fmemb and
ligand-receptor interaction Fligand only [8,9,18,37]. With the current
study we provide evidence that Fpolymer is important as well, and
eventually comparable in magnitude with Fmemb. Therefore, in the
design of PEGylated NPs, the contribution of Fpolymer should be
taken into account. A similar conclusion about the relevance of the
polymer contribution was recently put forward in the study of
mechanisms of harvesting cells cultured on thermoresponsive
polymer brushes [60,61].
From the above analysis, the free energy change of the whole
system F is obtained. For a given sp , there exists a critical binding
strength εb for which F ¼ 0. Beyond this critical value, complete
wrapping of the PEGylated NP is energetically favorable. Theb
ted with targeting moieties) for a PEGylated NP: (a) before endocytosis and (b) after
1:6 chains/nm2. In (a), the solid lines are given by the SCF calculations.
a b
Fig. 5. Free energy change of grafted PEG polymers during endocytosis: (a) free energy per monomer Fp=NkBT and (b) free energy change of all grafted chains Fpolymer. In (a), the
dashed lines guide eyes. In (b), the bending energy change of membrane is Fmembx251kBT .
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To further conﬁrm our analytical predictions, we ran simulations
with different ligand-receptor binding strengths εb. According to
the different values of εb, the ﬁnal trajectories of DPD simulations
can be grouped into two classes: fully wrapped and partially
wrapped regimes. The simulation results agree well with our
theoretical predictions only if Fpolymer is taken into account, as
demonstrated in Fig. 6.
3.4. Effect of grafted PEG molecular weight
As previously mentioned, the molecular weight of grafted PEG
polymers typically varies between 550 and 5000 Da [26e30,32,33].
To understand the effect of N, we study another set of PEGylated
NPs with larger N. The core of the NP is still about 8 nm, while the
grafted PEG has N ¼ 36 monomers (corresponding to molecularFig. 6. Phase diagram of receptor-mediated endocytosis of PEGylated NPs, obtained
from DPD simulations and theoretical predictions. The phase diagram is given as a
function of the ligand-receptor binding strength εb and sp. The results are classiﬁed
into partially wrapped (: symbols) and fully wrapped regimes (C symbols). The core
diameter of PEGylated NPs is 8 nm and N ¼ 18. The dashed line is predicted by
considering the balance between Fmemb, Fpolymer and Fligand.weight 1630 Da), twice its value of the previous case (their con-
formations are given in Fig. S10 of SI). Due to the limit of compu-
tation, the larger values of N are not considered in current work.
The radius R of PEGylated NPs and average volume Vpolymer per
chain are given in Table 2. Again, we ﬁnd that R increases linearly
with sp, while Vpolymer decreases nonlinearly with sp (SI Fig. S11).
All these observations are in good agreement with the PEGylated
NPs with lower degree of polymerization, N ¼ 18 (Table 1), and
experimental observations on PEGylated Au NPs [33]. Comparing
with the previous PEGylated NPs (N ¼ 18), the radius R for PEGy-
lated NPs with N ¼ 36 has been increased by about 2 nm for a given
sp. Such an increment may have an impact on the internalization
rate of PEGylated NPs (to be discussed below).
Fig. 7 shows the internalization pathway for a PEGylated NP
with sp ¼ 1:6 chains/nm2 and N ¼ 36. Similar to the PEGylated NPs
with shorter grafted chains (see Fig. 2), the endocytosis process can
be classiﬁed into three stages: membrane bending stage
(0< t <1946 ns), membrane monolayer protruding stage
(1946< t <5000 ns) and equilibrium stage (t >5000 ns). In the
course of this process, the Ree of grafted PEG polymers initially
increases monotonically with time (Fig. S12 of SI), as the targeting
moieties conjugated with free ends of tethered chains bind with
receptors on themembrane. Before the PEGylated NP is wrapped by
the membrane, the targeting moieties are hidden inside of the
tethered layer of PEG polymer to minimize the free energy Fpolymer.
When the PEGylated NP is wrapped by the membrane, the grafted
PEG polymers are stretched out to bind with the receptors in the
membrane, signiﬁcantly reducing Fligand. The energy released by
the ligand-receptor binding provides the driving force for the
bending of the membrane and the stretching of grafted PEG poly-
mers. Until the PEGylated NP is fully wrapped by the membrane,
Ree drops to a smaller value to reduce the free energy Fpolymer.
Comparing the Ree values before and after endocytosis, the grafted
chains are more stretched for N ¼ 36 than that of N ¼ 18. Such a
difference indicates a dramatic change of free energy of grafted PEG
polymers with N ¼ 36 (cf. Eq. (2)). Besides, in contrast to N ¼ 18,
there are other distinct features for PEGylated NPs with N ¼ 36.
First, the internalization rate of PEGylated NPs is greatly affected
by N. The wrapping ratio of PEGylated NPs with N ¼ 36 is shown in
Fig. 8. Comparing with the shorter N ¼ 18 chains (Fig. 3), the
internalization rate of PEGylated NPs is signiﬁcantly slowed down
due to the increase of N. For example, when sp ¼ 1:4 chains/nm2 it
Table 2
Effect of grafting density sp (number of grafted chains M) on the radius R of
PEGylated NPs, average volume Vpolymer occupied by a single grafted chain, radius of
gyration Rg, and end-to-end distance Ree of grafted chains. The core diameter is 8 nm
and the grafted PEG length is N ¼ 36 (corresponding to molecular weight 1630 Da).
Fpolymer represents the free energy change of grafted chains before and after
internalization.
Before endocytosis After endocytosis
sp
Chains/nm2
M R
nm
Vpolymer
nm3
Rg
nm
Ree (before)
nm
Ree (after)
nm
Fpolymer
kBT
0.2 40 6.66 24.28 1.52 4.02 N/A N/A
0.4 80 7.03 14.81 1.55 4.20 N/A N/A
0.6 121 7.36 11.60 1.59 4.38 N/A N/A
0.8 161 7.62 9.83 1.62 4.51 N/A N/A
1.0 201 7.91 8.97 1.66 4.70 N/A N/A
1.2 241 8.13 8.22 1.69 4.82 5.37 203.21
1.4 281 8.39 7.86 1.74 5.01 5.31 315.47
1.6 322 8.60 7.44 1.77 5.15 5.31 361.05
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wrapped. However, the wrapping time is increased to 6000 ns for
N ¼ 36. Thus, the wrapping time is increased by a factor 6, while N
is doubled. As we have noticed, the radius R of PEGylated NP ist=5ns t=12ns
t=4
t=1946ns t=3320ns t=4
Fig. 7. Representative DPD simulation snapshots for endocytosis of PEGylated NP. The whole
membrane monolayer protruding stage (1946< t <5000 ns) and equilibrium stage (t >5000
ligand-receptor binding strength is εb ¼ 6:2kBT . For clarity, the solvent (water) molecules aenlarged from 6.60 to 8.39 nm, as N is enlarged from 18 to 36.
Therefore, the internalization rate of the PEGylated NP can be
reduced by increasing its size [8,10,18]. In addition to this size effect,
the free energy change of the grafted PEG polymers also plays an
important role. Using our SCF calculations (SI Section 4), the free
energy changes Fpolymer of longer grafted chains can be quantiﬁed
as well (Table 2 and Fig. 5). For sp ¼ 1:4 chains/nm2,
Fpolymer ¼ 120:47kBT and 315:47kBT for N ¼ 18 and 36, respec-
tively. Upon doubling N, Fpolymer for N ¼ 36 is about 2.6 times
Fpolymer for N ¼ 18. This previously ignored free energy penalty
induced by longer grafted PEG polymers can further delay the
internalization process of PEGylated NPs.
Second, the free energy change Fpolymer of grafted PEG polymers
can be larger than the bending energy Fmemb of the membrane and
plays an important role during endocytosis. When N ¼ 18, Fpolymer
varies between 10 and 156kBT depending on sp. However, for
N ¼ 36, Fpolymer varies between 200 and 360kBT , for sp ¼ 1:2 to
1.6 chains/nm2, and can thus exceed the bending energy of the
membrane Fmemb ¼ 251kBT (see Fig. 5b). As previously mentioned,
the grafted PEG chains can be as large as N ¼ 112 with
sp ¼ 1:2 1:6 chains/nm2 [33] for PEGylated Au NPs. Thus, we
expect the free energy change Fpolymer to be further enlarged. In this9ns
t=122ns
584ns t=5217ns
process can be classiﬁed into three stages: membrane bending stage (0< t <1946 ns),
ns). The core diameter of the NP is 8 nm, sp ¼ 1:6 chains/nm2 with N ¼ 36 PEG. The
re not rendered. The color scheme is identical with the one chosen for Fig. 2.
A3 A4
A1 A2
Fig. 8. Effect of grafting density on the wrapping ratio of PEGylated NPs. The core diameter of PEGylated NPs is 8 nm, grafted with N ¼ 36 PEG. The ligand-receptor binding strength
is εb ¼ 6:2kBT . Wrapping ratios 0 and 1 denote the unwrapped and completely wrapped states, respectively. The snapshots A1-A4 for endocytosis of PEGylated NPs with different
grafting densities are given on right. The color scheme is as the same as that given in Fig. 2.
Y. Li et al. / Biomaterials 35 (2014) 8467e84788476case, Fpolymer will be much larger than Fmemb and will play the
dominant role during the endocytosis. Ignoring the contribution of
Fpolymer for designing PEGylated NPs may prohibit successful drug
delivery as the PEGylated NPs cannot be fully wrapped by the
membrane (cf. Fig. 6).
4. Discussion
The above simulation results and theoretical analysis may shed
light on understanding and explaining the experimental observa-
tions on endocytosis of PEGylated NPs. As uncovered in the ex-
periments, the cellular uptake efﬁciency of PEGylated NP,
proportional to its internalization rate, heavily depends on the size
of the core and grafting (ligand) density of PEG polymers
[28,30,32,33]. To evaluate the cellular uptake efﬁciency from our
DPD simulation results, we take the wrapping time tw, i.e. the time
to be fully wrapped by the membrane, for the PEGylated NP with
sp ¼ 1:0 chains/nm2 as a baseline. The cellular uptake of the
PEGylated NPs can be calculated as tw=twðspÞ, where twðspÞ is the
time for a PEGylated NP at grafting density sp to be fully internal-
ized (wrapping ratio unity). If the PEGylated NP cannot be fully
internalized (long-lived partial wrapping), we take the wrapping
time twðspÞ ¼ ∞. The cellular uptake of PEGylated NPs with
different grafting densities is given in Fig. 9a with ligand-receptor
binding strength 6.2 kBT . As we have observed in Fig. 3, when sp
is small, the cellular uptake efﬁciency is small as well. The efﬁciency
rapidly increases and saturates at high spe0:8 chains/nm2 where
the cellular uptake efﬁciency exceeds 80%. Walkey et al. have
studied the serum-independent J774A.1 uptake of PEGylated Au
NPs in serum-free media [33]. They suggest that uptake results
from direct interactions between the distal methoxy group at the
free ends of the PEG chains and the membrane surface proteins or
lipids [33,49]. These interactions can be weaker hydrophobic in-
teractions or hydrogen bonding [33,49], with binding strength
ranging from 2 to 7 kBT [62]. Therefore, these methoxy groups at
free ends of PEG polymers essentially act as ‘weak’ and ‘non-spe-
ciﬁc’ targeting moieties by interacting with cell-surface bio-
molecules. A similar mechanism is at play in our case. The J774A.1
uptake of PEGylated Au NPs is also given in Fig. 9a for comparison
with our simulation results. Interestingly, we ﬁnd the cellular up-
take predicted by our DPD simulations to agree reasonably well
with their experimental measurements, although the corediameter of PEGylated Au NPs is about 15 nmwith grafted PEGwith
N ¼ 112 monomers [33]. Above sp ¼ 0:8 chains/nm2, they also ﬁnd
the cellular uptake to completely saturate. The qualitative agree-
ment between our simulation results and the experimental ob-
servations on the cellular uptake further verify and validate our
model and methodology. More importantly, the optimal
spe0:8 chains/nm2, predicted by the DPD simulations is in agree-
ment with the experimental results. Representative TEM images for
J774A.1 uptake of PEGylated Au NPs with grafting density
0.96 chains/nm2 are displayed in Fig. 9b. At this high grafting
density, most of the PEGylated NPs are taken up by the cell, in
contrast to the PEGylated NPs with 0.2 chains/nm2 distributed at
the cellular periphery (Fig. 3). Moreover, these PEGylated NPs are
mostly dispersed at low density in the cytoplasm.
As shown in the phase diagram (Fig. 6), an optimal
sp ¼ 0:8 chains/nm2 corresponds to the density at which the critical
binding strength εb levels off. From the cellular uptake efﬁciency
estimated in Fig. 9, such an optimal sp also allows efﬁcient inter-
nalization of PEGylated NPs. Experimentally, at this grafting density
the adsorption of serum protein of PEGylated Au NPs has been
tremendously reduced, and the corresponding non-speciﬁc
macrophage uptake is dramatically decreased [30,33]. Therefore,
the optimal spe0:8 chains/nm2, not only balances Fligand with Fmemb
and Fpolymer, but also reduces the opsonization at the same time.
The current model also has certain limitations. As it has been
discussed in the previous work [17], the computational models
usually use very high ligand and receptor densities to accelerate
simulations [15,20,21,42,58,63], owing to the extremely high
computational costs. Therefore, the internalization rate of the NPs
from simulations is typically much faster than that observed from
experiments [7,64]. Besides, the speciﬁc ligand-receptor in-
teractions are simpliﬁed as attractive interactions to further reduce
the computational costs [15,20,21,42,58,63], which may alter the
entropy and free energy of the binding due to the ﬂexure of re-
ceptors [54,55,65]. However, the endocytic kinetics can also be
quantitatively captured by these accelerated simulations, for NPs
with different sizes, shapes and ligand densities
[2,15,16,20,22,35,37,39,40,43,57]. Thus, the simulation results given
by the present study still provide the detailed understandings on
the internalization behaviors of PEGylated NPs.
Both grafting (ligand) density sp and degree of polymerization N
of grafted PEG are found to play important roles during cellular
ba B1 B2
B3 B4
Fig. 9. Effect of grafting density on the cellular uptake efﬁciency, which is proportional to the internalization rate of PEGylated NPs. The core diameter of PEGylated NPs is 8 nmwith
grafted PEG of N ¼ 18. The ligand-receptor binding strength is εb ¼ 6:2kBT . In (a), Experimental results by Walkey et al. [33] for J774A.1 uptake of PEGylated Au NPs are shown for
comparison with our DPD results. (b) Representative TEM images on the intracellular distribution of PEGylated Au NPs with grafting density 0.96 chains/nm2 and core diameter
15 nm (B1:scale bar ¼ 1000 nm. B2eB4: scale bar ¼ 100 nm). Images B1eB4 are reproduced with permission from Walkey et al. [33].
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tion and free energy barrier created by Fpolymer is very strong, which
has not been considered in the previous experimental studies. Due
to the high computational demanding for larger values of N, it is a
forbidden challenge for the present work to computational study
the internalization rates of PEGylated NPs with larger molecular
weights. We expect the current simulation results can motivate
future experiments to elucidate the critical role played by N.
5. Conclusion
In summary, we have performed large scale DPD simulations on
receptor-mediated endocytosis of PEGylated NPs with different
grafting densities sp and polymerization degrees N. All the free
ends of grafted PEG polymers are conjugated with targeting moi-
eties by mimicking the experimental conditions, which can spe-
ciﬁcally recognize and bind to receptors expressed over the cell
membrane. The PEGylated NPs with high grafting (ligand) densities
can be more easily wrapped by a zero-tension and receptor rich
(50%) lipid bilayer, driven by the ligand-receptor binding energy,
than PEGylated NPs with low grafting (ligand) densities. The non-
speciﬁc steric repulsion, Fpolymer, induced by the PEG polymers
conﬁned by the membrane, is found to be comparable, or even
larger than, the bending energy of the membrane Fmemb during
endocytosis based on our SCF calculations. Therefore, for internal-
ization to occur, the ligand-receptor binding energy, Fligand, must be
large enough to overcome the energy barriers created by Fmemb and
Fpolymer. The critical ligand-receptor binding strength for PEGylated
NPs to be fully wrapped can be correctly predicted by a simple
analytical equation, by including the contribution from Fpolymer.
Under a ﬁxed core diameter (8 nm) and polymerization degree of
the grafted PEG chains (N ¼ 18), an optimal grafting density
spe0:8 chains/nm2 is identiﬁed, which balances Fligand with Fmemb
and Fpolymer, and enables the PEGylated NP to be quickly accepted
by the cell. At the same time, this optimal sp prevents the ab-
sorption of serum-protein and reduces the non-speciﬁc uptake of
PEGylated NPs by macrophages. For grafted PEG polymers with
larger N ¼ 36, the overall size of the PEGylated NPs is larger as well,
leading to a reduced internalization rate. Fpolymer for N ¼ 36 is also
found to be 2e3 times larger than that of N ¼ 18, indicating thatFpolymer can play the dominant role during the endocytosis of
PEGylated NPs with long grafted PEG chains. These ﬁndings are of
immediate interests to the study of cellular uptake of PEGylated
NPs and can be further utilized in the design of PEGylated NPs in
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